A summary of IPOs from companies in the biotech and pharma world since February 1, 2019.
February 2019 IPO Filings and Pricings, Updated 2/28/19
Know of an IPO since Feb. 1, 2019 that we missed? Email us at news@biospace.com.
Related: Check out BioSpace’s January list.
| Date | Company Name | Amount (USD) | Company HQ | Research Focus |
|---|---|---|---|---|
| 2/28/19 | Kaleido Biosciences | $75M Priced | Lexington, MA | Modulate the metabolic output and profile of the body’s microbiome |
| 2/28/19 | GENFIT CORP. | $100M Filed | Loos, France | Drug candidates and diagnostic solutions for metabolic and liver-related diseases |
| 2/15/19 | Hoth Therapeutics | $7M Priced | New York City, NY | Proprietary therapeutics for atopic dermatitis |
| 2/14/19 | Stealth Biotherapeutics | $78M Priced | Newton, MA | Novel therapies for diseases involving mitochondrial dysfunction |
| 2/14/19 | Avedro | $70M Priced | Waltham, MA | Technology for corneal ectatic disorders and refractive conditions |
| 2/13/19 | TCR2 Therapeutics | $75M Priced | Cambridge, MA | Novel T-cell therapies using multi-format TRuC platform |
| 2/12/19 | Anchiano Therapeutics | $30.5M Priced | Jerusalem, Israel | Genetic therapy for early-stage bladder cancer |
| 2/8/19 | Shockwave Medical | $70M Filed | Santa Clara, CA | Devices that break up calcium deposits in CV system via sonic waves |
| 2/7/19 | Harpoon Therapeutics | $75.6M Priced | San Francisco, CA | T cell engagers that harness the immune system to treat cancer and other diseases |
| 2/7/19 | Gossamer Bio | $276M Priced | San Diego, CA | Therapeutics in the disease areas of immunology, inflammation, and oncology |
| 2/6/19 | Alector | $176M Priced | San Francisco, CA | Develop therapies that empower the immune system to cure neurodegeneration |
| 2/1/19 | Hoth Therapeutics | $7.5M Filed | New York City, NY | Proprietary therapeutics for atopic dermatitis |
